Variables | (N = 1,493) | % |
---|---|---|
Gender (male) N (%) | 970 | 65.0% |
Age (years) mean (SD) | 63 | 18 |
Race N (%) | ||
White | 1381 | 92.5% |
Comorbidities N (%) | ||
DM | 541 | 36.2% |
AH | 537 | 36.0% |
HD | 528 | 35.4% |
COPD | 153 | 10.2% |
Malignant solid tumor | 200 | 13.4% |
Hematologic malignances and BMT | 107 | 7.2% |
Cirrhosis/other liver diseases | 100 | 6.7% |
Solid organ transplant | 526 | 35.2% |
Liver | 509 | 34.1% |
Heart | 14 | 0.9% |
Lung | 2 | 0.1% |
Multivisceral | 1 | 0.1% |
Type of patient N (%) | ||
Medical | 1094 | 73.3% |
Surgical | 399 | 26.7% |
Reason for admission to ICU N (%) | ||
Infection | 577 | 38.6% |
Cardiovascular disease | 399 | 26.7% |
Pancreatitis | 58 | 3.9% |
Bleeding | 48 | 3.2% |
Intoxication | 12 | 0.8% |
Surgical urgency | 339 | 22.7% |
Elective surgery | 19 | 1.3% |
Trauma | 33 | 2.2% |
Major burn | 8 | 0.5% |
AKI etiology N (%) | ||
Sepsis | 839 | 56.2% |
Low cardiac output | 270 | 18.1% |
RRT modality N (%) | ||
IHD | 501 | 33.6% |
CVVHDF | 992 | 66.4% |
Death N (%) | 805 | 53.9% |
Baseline creatinine (mg/dl) median (IQR) | 0.9 | (0.7–1.5) |
eGFR–ml/min/1.73 m2 median (IQR) | 84 | (49–106) |
APACHE II median (IQR) | 23 | (18–30) |
ICU length of stay (days) - median (IQR) | 12 | (6–24) |
Hospital length of stay (days) - median (IQR) | 30 | (15–52) |